Browse By Topic Clinical Microbiology
ASM Hails Game-Changing Investment in Genomic Surveillance Enacted in American Rescue Plan
ASM hails the inclusion of $1.75 billion for CDC’s Advanced Molecular Detection (AMD) program in the American Rescue Plan Act signed into law by President Biden.
ASM Responds to House Committee Hearing on COVID Response
ASM responds to the House Energy & Commerce Subcommittee on Health Hearing: “Road to Recovery: Ramping Up COVID-19 Vaccines, Testing and Medical Supply Chain."
Laboratory Supply Shortages Are Impacting COVID-19 and Non-COVID Diagnostic Testing
The shortage of laboratory supplies associated with the high demand for COVID-19 testing have been continuously impacting the laboratory supply chain since the early days of the pandemic. Now, new reports of concerning and unprecedented supply shortages for non-COVID-19-related tests are emerging and affecting diagnostic testing for a variety of other diseases.